Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04303247Early Phase 1Unknown
CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL
B-cell Lymphoma RecurrentB-cell Lymphoma Refractory
Principalinvestigator
NCT04516551Phase 1Unknown
Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT
B Cell LeukemiaRelapsed Adult ALL
Studychair

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

He Huang, MD

First Affiliated Hospital of Zhejiang University

Related
15 trials

Shared therapeutic areas:

Leukemia, B-CellRelapsed Adult ALL

Worked with same sponsors:

920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaChongqing University Cancer Hospital+8 more
Collaborated on 1 trial
Similarity Score24%

Yuankai Shi, Phd

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
5 trials

Shared therapeutic areas:

B-cell Lymphoma RecurrentB-cell Lymphoma Refractory
Similarity Score15%

Carlos Ramos, MD

Baylor College of Medicine

Related
3 trials

Shared therapeutic areas:

Leukemia, B-CellRelapsed Adult ALL
Similarity Score15%

Rong Tao, MD

Fudan University

Related
5 trials

Shared therapeutic areas:

B-cell Lymphoma RecurrentB-cell Lymphoma Refractory
Similarity Score15%

Fang Liu, MD, PhD

The General Hospital of Western Theater Command

Related
2 trials

Shared therapeutic areas:

Leukemia, B-Cell

Worked with same sponsors:

The General Hospital of Western Theater Command
Similarity Score8%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Leukemia, B-Cell
Similarity Score8%

Li Li, MD

Kunming Hope of Health Hospital

Related
2 trials

Shared therapeutic areas:

Leukemia, B-Cell
Similarity Score8%

Hanying Bao, PhD

Shanghai YingLi Pharmaceutical Co. Ltd.

Related
4 trials

Shared therapeutic areas:

B-cell Lymphoma Recurrent
Similarity Score8%

Bilal Omer, MD

Baylor College of Medicine

Related
7 trials

Shared therapeutic areas:

Leukemia, B-Cell
Similarity Score8%

Colleen Annesley, MD

Seattle Children's Hospital

Related
7 trials

Shared therapeutic areas:

Leukemia, B-Cell
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04303247Early Phase 1PrincipalInvestigator

CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL

B-cell Lymphoma RecurrentB-cell Lymphoma Refractory
Unknown
NCT04516551Phase 1StudyChair

Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

B Cell LeukemiaRelapsed Adult ALL
Unknown

All 2 trials loaded